Fig. 2: Constraining cohort of COVID-19 ICU patients to those who had at least one plasma IL-6 measurement before and after corticosteroid administration. | Cell Death Discovery

Fig. 2: Constraining cohort of COVID-19 ICU patients to those who had at least one plasma IL-6 measurement before and after corticosteroid administration.

From: Plasma IL-6 levels following corticosteroid therapy as an indicator of ICU length of stay in critically ill COVID-19 patients

Fig. 2

A Longitudinal measurements of plasma IL-6 in hospitalized patients who received non-topical corticosteroids at least one time at or after the diagnosis of COVID-19 via SARS-CoV-2 PCR. B Relationship between duration of ICU stay and change in plasma IL-6 levels before and after steroid administration (patient numbers are mapped onto Fig. 8a). If multiple pre/post-corticosteroid administration levels are available, the mean is used. C Contingency table used to determine if a significant relationship exists between extended ICU stay and IL-6 measurement trend pre- and post-corticosteroid administration.

Back to article page